Search by Drug Name or NDC
NDC 68462-0687-01 tacrolimus 5 mg/1 Details
tacrolimus 5 mg/1
tacrolimus is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is TACROLIMUS.
MedlinePlus Drug Summary
Tacrolimus (Astagraf XL, Envarsus XR, Prograf) is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) in people who have received a kidney transplant. Tacrolimus (Prograf) is also used along with other medications to prevent rejection in people who have received a liver, lung, or heart transplant. Tacrolimus is in a class of medications called immunosupressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted organ.
Related Packages: 68462-0687-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tacrolimus
Product Information
| NDC | 68462-0687 |
|---|---|
| Product ID | 68462-687_222e5e02-7296-4d3f-adf7-4d412eee7957 |
| Associated GPIs | 99404080000120 |
| GCN Sequence Number | 021797 |
| GCN Sequence Number Description | tacrolimus CAPSULE 5 MG ORAL |
| HIC3 | Z2E |
| HIC3 Description | IMMUNOSUPPRESSIVES |
| GCN | 28492 |
| HICL Sequence Number | 020974 |
| HICL Sequence Number Description | TACROLIMUS |
| Brand/Generic | Generic |
| Proprietary Name | tacrolimus |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | tacrolimus |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | TACROLIMUS |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206662 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68462-0687-01 (68462068701)
| NDC Package Code | 68462-687-01 |
|---|---|
| Billing NDC | 68462068701 |
| Package | 100 CAPSULE in 1 BOTTLE (68462-687-01) |
| Marketing Start Date | 2020-11-10 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.25517 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis